HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuho Najima Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

1/2018Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia.
1/2018Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response-The final results of the D-first study.
1/2017[Disseminated fusariosis in patients with acute leukemia: a retrospective analysis of three cases].
1/2016Chronic myeloid leukemia relapsing ten years after allogenic bone marrow transplantation.
1/2016Retrospective analysis of clinical outcomes of the patients with chronic myeloid leukemia who stopped administration of tyrosine kinase inhibitors: a single institution experience.
1/2016Occurrence of Donor Cell-derived Lymphoid Blast Crisis 24 Years Following Related Bone Marrow Transplantation for Chronic Myeloid Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuho Najima Research Topics

Disease

24Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2022 - 04/2013
13Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2022 - 02/2016
12Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 12/2015
12Leukemia
01/2020 - 02/2010
10Neoplasms (Cancer)
08/2022 - 07/2003
8Infections
01/2022 - 05/2009
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 01/2016
5Philadelphia Chromosome
01/2022 - 01/2020
5Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 01/2008
3Lymphoma (Lymphomas)
11/2021 - 01/2018
3Bronchiolitis Obliterans Syndrome
01/2021 - 12/2016
3Bacteremia
08/2020 - 01/2017
3Residual Neoplasm
01/2020 - 05/2010
3Multiple Myeloma
07/2019 - 01/2019
3Pneumonia (Pneumonitis)
12/2018 - 01/2016
2Anemia
01/2022 - 01/2019
2Disease Progression
01/2022 - 01/2017
2Aplastic Anemia (Anemia, Hypoplastic)
01/2022 - 01/2020
2Hematologic Neoplasms (Hematological Malignancy)
03/2021 - 01/2019
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2021 - 01/2017
2Abscess
01/2021 - 02/2019
2Adenoviridae Infections (Adenovirus Infections)
12/2020 - 05/2019
2Pathologic Complete Response
07/2019 - 02/2016
2Thrombocytopenia (Thrombopenia)
05/2019 - 05/2009
2Mycoses (Diseases, Fungus)
02/2019 - 12/2015
2Pleural Effusion (Pleural Effusions)
01/2019 - 01/2016
2Heart Failure
01/2019 - 01/2016
2Blast Crisis (Blast Phase)
01/2017 - 01/2016
2Pain (Aches)
04/2016 - 01/2016
2Obesity
05/2004 - 12/2003
1Cardiotoxicity
10/2022
1Mucormycosis
12/2021
1Paraplegia (Spastic Paraplegia)
12/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2021
1Pneumococcal Infections
08/2021
1Tuberculosis (Tuberculoses)
01/2021
1Lymphopenia (Lymphocytopenia)
01/2021
1Rupture
12/2020
1Virus Diseases (Viral Diseases)
12/2020
1Brain Abscess (Abscess, Brain)
12/2020
1Sepsis (Septicemia)
08/2020
1Bone Resorption
08/2020
1Osteoporosis
08/2020
1Candidemia
01/2020
1Spinal Cord Diseases
01/2020
1Acquired Immunodeficiency Syndrome (AIDS)
01/2020
1Nocardia Infections
12/2019

Drug/Important Bio-Agent (IBA)

5Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022 - 01/2019
5SteroidsIBA
01/2022 - 10/2016
5Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2022 - 01/2020
4fludarabineIBA
01/2022 - 01/2020
4Dasatinib (BMS 354825)FDA Link
01/2018 - 06/2015
3Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2016
3Dexamethasone (Maxidex)FDA LinkGeneric
05/2019 - 01/2016
2Busulfan (Busulfex)FDA Link
01/2022 - 12/2021
2thymoglobulinFDA Link
01/2022 - 01/2020
2AntigensIBA
01/2022 - 02/2016
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
06/2021 - 02/2017
2FoscarnetFDA LinkGeneric
12/2020 - 01/2008
2Phosphotransferases (Kinase)IBA
11/2019 - 10/2018
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2019 - 11/2016
2pomalidomideIBA
07/2019 - 05/2019
1CCAAT-Enhancer-Binding Protein-alphaIBA
11/2022
1Pyridinolcarbamate (P23)IBA
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022
1Prednisolone (Predate)FDA LinkGeneric
01/2022
1Chimeric Antigen ReceptorsIBA
11/2021
1CalreticulinIBA
10/2021
1ruxolitinibIBA
10/2021
1Calcineurin InhibitorsIBA
06/2021
1Methotrexate (Mexate)FDA LinkGeneric
06/2021
1Tacrolimus (Prograf)FDA LinkGeneric
01/2021
1Cidofovir (Vistide)FDA Link
12/2020
1Pharmaceutical PreparationsIBA
12/2020
1PrebioticsIBA
10/2020
1Alkaline PhosphataseIBA
08/2020
1tartaric acid (tartrate)FDA Link
08/2020
1AcidsIBA
08/2020
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2020
1MethylprednisoloneFDA LinkGeneric
01/2020
1Lenalidomide (CC 5013)FDA Link
07/2019
1plerixaforFDA Link
07/2019

Therapy/Procedure

41Hematopoietic Stem Cell Transplantation
10/2022 - 05/2009
13Therapeutics
08/2022 - 01/2008
12Transplantation
06/2021 - 05/2009
11Drug Therapy (Chemotherapy)
01/2022 - 02/2010
10Stem Cell Transplantation
11/2021 - 12/2014
9Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2022 - 01/2008
9Cell Transplantation
11/2021 - 05/2018
3Radiotherapy
09/2018 - 05/2009
2Homologous Transplantation
08/2022 - 01/2016
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2022 - 05/2019
1Autologous Transplantation
11/2021
1Hepatectomy
01/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021
1Remission Induction
12/2020
1Catheters
08/2020
1Hematopoietic Stem Cell Mobilization
07/2019
1Salvage Therapy
05/2019